Table 3D.
Quality of life in patients with Crohn’s disease, ulcerative colitis, spondylarthritis, rheumatoid arthritis, psoriatic arthritis, and chronic plaque psoriasis (SF36 and EQ5D).
| Author (Year) | Time | Groups (patients allocated) |
SF-36 FF | SF-36 LRF | SF-36 Pain | SF-36 SG | SF-36 BE | SF-36 LRE | SF-36 FS |
SF-36 EF |
SF-36 RCF | SF-36 RCM | EQ 5D |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jørgensen et al. (2017) | Exchange: Week 0 | INF/INF (n=241) |
Baseline:
50.6 (11.3) End: –1.2 (7.0) |
Baseline:
45.6 (11.6) End: –1.1 (11.2) |
Baseline:
47.2 (8.5) End: –0.7 (7.3) |
Baseline:
43.5 (10.2) End: –1.1 (7.3) |
Baseline:
50.0 (9.8) End: –1.3 (7.8) |
Baseline:
48.8 (10.8) End: –0.5 (12.2) |
Baseline:
48.0 (10.5) End: –0.2 (9.4) |
Baseline:
47.1 (10.4) End:–1.9 (8.5) |
Baseline:
46.4 (10.1) End: –1.2 (6.9) |
Baseline:
49.1 (10.7) End: –0.7 (8.9) |
Baseline:
0.8 (0.2) End: 0.0 (0.2) |
| End: Week 52 | INF/CT-P13 (n=240) |
Baseline:
50.5 (10.9) End: 0 (6.3) |
Baseline:
46.9 (11.3) End: –0.4 (9.4) |
Baseline:
47.8 (9.5) End: –0.5 (7.7) |
Baseline:
44.5 (10.2) End: –1.1 (7.1) |
Baseline:
50.9 (8.9) End: –0.7 (7.8) |
Baseline:
50.0 (10.4) End: –2.4 (10.5) |
Baseline:
48.6 (9.5) End: –0.6 (10.4) |
Baseline:
46.9 (10.2) End: 0.5 (8.3) |
Baseline:
46.8 (10.3) End: 0.2 (6.6) |
Baseline:
50.3 (9.3) End: –1.3 (8.9) |
Baseline:
0.8 (0.2) End: 0.0 (0.2) |
|
| Estimated p-value | 0.103 | 0.0069 | 0.4096 | 0.6677 | 0.999 | 0.026 | 0.1183 | 0.7129 | 0.4921 | 0.999 | 0.999 |
SF-36, 36-Item Short Form Health Survey; FF, Physical functioning; LRF, Limitation of physical roles; SG, General Health; BE, Emotional wellbeing; LRE, Limitation of emotional roles; FS, Social Functioning; EF, Energy or Fatigue; RCF, Physical component summary; RCM, Mental component summary; Baseline, exchanging time; End, Conclusion of follow-up.